UPDATE: Wedbush Initiates Coverage on OvaScience on Strong Augment Potential

In a report published Thursday, Wedbush analyst Zarak Khurshid initiated coverage on OvaScience (NASDAQ: OVAS ) with an Outperform rating and $20.00 price target. In the report, Wedbush noted, “We are initiating coverage of OvaScience (OVAS) with an OUTPERFORM rating and a $20 12-month price target. OVAS is developing products